Your browser doesn't support javascript.
loading
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas.
Goss, P; Stewart, A K; Couture, F; Klasa, R; Glück, S; Kaizer, L; Burkes, R; Charpentier, D; Palmer, M; Tye, L; Dulude, H.
Affiliation
  • Goss P; Toronto Hospital, Canada.
Leuk Lymphoma ; 34(3-4): 295-304, 1999 Jul.
Article in En | MEDLINE | ID: mdl-10439366
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Lymphoma / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Canadá
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Lymphoma / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Canadá